|
 |
 |
 |
 |
 |
 |
|
|
|
538
|
½Ä¾àó: 2016³âµµ ºÐ¾ßº° ÀÚÁÖ ÇÏ´Â Áú¹®(FAQ)Áý ¹ß°£[1]
|
0 |
°ü¸®ÀÚ |
2016-12-27 |
547 |
|
|
537
|
½Ä¾àó: ´ëÇѹα¹¾àÀü(11°³Á¤) ÀϺΠ°³Á¤
|
0 |
°ü¸®ÀÚ |
2016-12-27 |
358 |
|
|
536
|
½ÄÇ°ÀǾàÇ°¾ÈÀüÆò°¡¿ø: ÇѾà(»ý¾à)Á¦Á¦ÀÇ ¼ººÐÇÁ·ÎÆÄÀÏ ¼³Á¤ °¡À̵å¶óÀÎ °³Á¤
|
0 |
°ü¸®ÀÚ |
2016-12-20 |
124 |
|
|
535
|
½ÄÇ°ÀǾàÇ° ¾ÈÀüÆò°¡¿ø: Çã°¡ ÈÄ Á¦Á¶¼Ò º¯°æÀ» À§ÇÑ ±â¼úÀÌÀü ½É»ç °¡À̵å¶óÀÎ Á¦Á¤
|
0 |
°ü¸®ÀÚ |
2016-12-20 |
187 |
|
|
534
|
ICH: Q11_QnA on the selection and justification of starting materials ¹ßÇà
|
0 |
°ü¸®ÀÚ |
2016-12-07 |
381 |
|
|
533
|
EMA: Guideline on process validation for finished products - information and data °³Á¤[1]
|
0 |
°ü¸®ÀÚ |
2016-12-07 |
350 |
|
|
532
|
½Ä¾àó: ÈÀåÇ° À§ÇØÆò°¡ °¡À̵å¶óÀÎÀ» °³Á¤
|
0 |
°ü¸®ÀÚ |
2016-12-05 |
170 |
|
|
531
|
FDA: Guidance for Industry: Contract Manufacturing Arrangements for Drugs: Quality Agreements¹ßÇà
|
0 |
°ü¸®ÀÚ |
2016-11-30 |
291 |
|
|
530
|
FDA Inspection °ÅºÎ »ç·Ê¿Í Warning Letter
|
0 |
°ü¸®ÀÚ |
2016-11-26 |
425 |
|
|
529
|
½Ä¾àó: ｢¿ì¼ö°Ç°±â´É½ÄÇ° Á¦Á¶±âÁØ｣ °³Á¤ °í½Ã
|
0 |
°ü¸®ÀÚ |
2016-11-25 |
185 |
|
|
